Latest Headlines

Latest Headlines

Judge accepts Merck unit's plea in Vioxx case

A Merck unit has pleaded guilty to a criminal misdemeanor charge as part of the whopping $950 million settlement of a federal probe into the illegal marketing of Vioxx.

Court: Man can't sue Medtronic for his paraplegia

An Arizona man lost a federal court appeal of his lawsuit claiming that a Medtronic ($MDT) pain pump left him paraplegic.

Justice, J&J duel over Gorsky's contribution to kickback case

Alex Gorsky's name has surfaced in the U.S. government's Risperdal marketing lawsuit just weeks before he is supposed to step up into the role of CEO at Johnson & Johnson.

Ex-Synthes employee fights back in generic device tussle

Synthes is fighting an ex-employee in court alleging, among other things, illegal use of proprietary information. This week, he's fighting back.

Judge lets sex-bias suit against Bayer go ahead

Bayer failed to stop 8 women from seeking class-action status for their sex-discrimination claims against the company.

Judge slams FDA for importing lethal-injection drugs

A U.S. judge sided with death row inmates who sued the FDA for importing a drug used in lethal injections. The prisoners had claimed the agency's decision to allow foreign versions of sodium thiopental into the U.S. violated its own drug-approval rules.

Judge chooses lead lawyers in Actos litigation

Two plaintiffs' lawyers experienced in pharma liability litigation have been tapped to lead the group managing thousands of suits alleging that Takeda Pharmaceutical's diabetes drug Actos caused bladder cancer, Bloomberg reports.

AstraZeneca sues FDA to block Seroquel copies

AstraZeneca is seeking an injunction to block Seroquel copies at least until a court can review its claims. The drugmaker says the FDA shouldn't be allowed to usher generic Seroquel onto the market until Dec. 2, when data exclusivity expires.

Litigation: Sanofi, Genzyme 'negligently allowed a virus contamination in the manufacturing facility'

Litigation is testing whether manufacturing problems at a pharmaceutical plant that led to a drug shortage can be considered legal negligence--as well as whether the manufacturer can be held accountable for patients' deaths.

Tekmira seeks court's rejection of Alnylam drug delivery patent suit

Tekmira Pharmaceuticals ($TKMR) fired back at Alnylam Pharmaceuticals ($ALNY) in federal court this week, with an attempt to get rid of the Massachusetts company's patent lawsuit over siRNA and lipid nanoparticle drug delivery technology.